A Phase 2 Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia
Public ClinicalTrials.gov record NCT01678755. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-126 in the Treatment of Cognitive Deficits in Schizophrenia (CDS) in Smokers
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an efficacy study evaluating a experimental treatment for cognitive deficits in adults with schizophrenia.
Study identification
- NCT ID
- NCT01678755
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 157 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 20 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2012
- Primary completion
- Feb 28, 2014
- Completion
- Feb 28, 2014
- Last update posted
- Jul 6, 2021
2012 – 2014
United States locations
- U.S. sites
- 20
- U.S. states
- 10
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Reference ID/Investigator# 74436 | Chino | California | 91710 | — |
| Site Reference ID/Investigator# 72704 | Garden Grove | California | 92845 | — |
| Site Reference ID/Investigator# 72699 | National City | California | 91950 | — |
| Site Reference ID/Investigator# 73983 | Oceanside | California | 92056 | — |
| Site Reference ID/Investigator# 73236 | Orange | California | 92868 | — |
| Site Reference ID/Investigator# 86974 | San Diego | California | 92102 | — |
| Site Reference ID/Investigator# 72701 | Torrance | California | 90502 | — |
| Site Reference ID/Investigator# 75314 | Bradenton | Florida | 34201 | — |
| Site Reference ID/Investigator# 75146 | Maitland | Florida | 32751 | — |
| Site Reference ID/Investigator# 75654 | Atlanta | Georgia | 30308 | — |
| Site Reference ID/Investigator# 72703 | Chicago | Illinois | 60640 | — |
| Site Reference ID/Investigator# 76534 | Hoffman Estates | Illinois | 60169 | — |
| Site Reference ID/Investigator# 73984 | Lake Charles | Louisiana | 70629 | — |
| Site Reference ID/Investigator# 73981 | St Louis | Missouri | 63109 | — |
| Site Reference ID/Investigator# 89553 | Marlton | New Jersey | 08053 | — |
| Site Reference ID/Investigator# 72700 | Cedarhurst | New York | 11516 | — |
| Site Reference ID/Investigator# 73982 | New York | New York | 10065 | — |
| Site Reference ID/Investigator# 113035 | Oklahoma City | Oklahoma | 73116 | — |
| Site Reference ID/Investigator# 72702 | DeSoto | Texas | 75115 | — |
| Site Reference ID/Investigator# 75147 | Houston | Texas | 77008 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01678755, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 6, 2021 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01678755 live on ClinicalTrials.gov.